AstraZeneca PLC (AZN)

53.97 +0.73  +1.37% NYSE Jul 14, 16:59 Delayed 2m USD

AstraZeneca Shareholders Equity (Quarterly):

10.78B for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Shareholders Equity (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Shareholders Equity (Quarterly) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 10.78B
Dec. 31, 2019 13.13B
Sept. 30, 2019 12.16B
June 30, 2019 13.55B
March 31, 2019 10.48B
Dec. 31, 2018 12.47B
Sept. 30, 2018 11.94B
June 30, 2018 12.64B
March 31, 2018 12.92B
Dec. 31, 2017 14.96B
Sept. 30, 2017 13.72B
June 30, 2017 13.65B
March 31, 2017 12.99B
Dec. 31, 2016 14.85B
Sept. 30, 2016 13.07B
June 30, 2016 13.53B
March 31, 2016 14.74B
Dec. 31, 2015 18.49B
Sept. 30, 2015 17.35B
June 30, 2015 18.28B
March 31, 2015 16.94B
Dec. 31, 2014 19.63B
Sept. 30, 2014 20.44B
June 30, 2014 22.03B
March 31, 2014 21.45B
   
Dec. 31, 2013 23.22B
Sept. 30, 2013 23.25B
June 30, 2013 23.22B
March 31, 2013 22.29B
Dec. 31, 2012 23.73B
Sept. 30, 2012 22.04B
June 30, 2012 22.03B
March 31, 2012 21.52B
Dec. 31, 2011 23.24B
Sept. 30, 2011 23.93B
June 30, 2011 23.61B
March 31, 2011 22.35B
Dec. 31, 2010 23.21B
Sept. 30, 2010 22.12B
June 30, 2010 22.09B
March 31, 2010 20.73B
Dec. 31, 2009 20.66B
Sept. 30, 2009 19.39B
June 30, 2009 17.80B
March 31, 2009 15.38B
Dec. 31, 2008 15.91B
Sept. 30, 2008 16.10B
June 30, 2008 15.97B
March 31, 2008 14.72B
Dec. 31, 2007 14.78B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Benchmarks

Benchmarks
GlaxoSmithKline PLC 16.20B
Emergent BioSolutions Inc 1.075B
Gilead Sciences Inc 22.07B

Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum 10.48B Mar 2019
Maximum 18.49B Dec 2015
Average 13.55B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.